Anti-Money-Laundering Duties in Life Insurance Sales

Anti-money-laundering duties in life sales start with a distinction: the federal insurance-company rule places the program obligation on the insurer, while agents and brokers participate through the carrier’s program. FinCEN’s insurance rule covers products with cash-value or investment features—generally individual permanent life insurance and individual annuities. The rule excludes term life and group life as defined products. An agent must follow carrier procedures for covered sales, report red flags internally, keep required records, and protect any suspicious-activity report information from disclosure.

Which life products are covered?

FinCEN defines a covered product functionally: a permanent life policy other than group life, an annuity contract other than a group annuity contract, and another insurance product with cash-value or investment features. The focus is on the product’s ability to store value, build value, or move an investment-like balance. A standard term policy generally has none of those features and is excluded, as is group life coverage under the rule’s definition.

This does not mean a term-life transaction can never involve fraud or criminal money. It means the insurance-company AML program rule’s covered-product definition does not treat ordinary term life as a covered product simply because it is life insurance. Other legal duties, insurer controls, fraud reporting systems, or laws may still apply. Read the product and the activity rather than making a blanket statement about all insurance business.

A permanent policy with cash value is more relevant because it can accumulate value that may be borrowed, surrendered, or transferred. A variable or indexed product may also have investment features. The precise covered status depends on the product’s terms and the regulatory definition, not its marketing label. If an agent is uncertain, the compliance office should identify whether the product is covered and what sales steps apply.

The insurer owns the program; the agent follows it

Under 31 CFR §1025.210, an insurance company that issues or underwrites covered products must maintain a written, risk-based AML program. The program includes internal controls, a compliance officer, ongoing employee training, and independent testing. FinCEN’s guidance says the insurer must integrate agents and brokers who sell covered products into its program and monitor their compliance. The rule does not require each ordinary insurance agent to create a separate insurer-style AML program solely because the agent sells life insurance.

That division of responsibility is easy to misstate. An agent is not the insurer’s AML officer, does not decide whether a SAR is legally required, and should not create an unauthorized parallel reporting system. But an agent is often the person who meets the customer, receives application information, observes payment arrangements, and learns why a product is being purchased. The insurer’s program can require the agent to ask questions, collect information, submit documents, escalate concerns, or complete training.

Carrier procedures can be stricter or more detailed than the federal rule’s minimum description. An insurer may require identity verification, explanation of source of funds, management approval for a large premium, documentation for a third-party payer, or a specific compliance hotline. Those are internal controls when implemented under the insurer’s program. Follow the current company procedure even when the agent’s legal role is not identical to the insurer’s statutory role.

A broker who also holds another regulated license may have separate duties under a different rule. For example, a securities broker-dealer distributing a variable product may have AML obligations under securities regulations for its securities activity. The insurance-company rule’s treatment of the insurer’s agent does not erase independent obligations the same person has in another capacity. Identify the entity, product, and regulatory role before giving a compliance answer.

What counts as a red flag?

FinCEN lists examples of activity that may warrant attention: buying a product inconsistent with the customer’s needs, using unusual payment methods, terminating a contract early—especially at a loss—directing a refund to an apparently unrelated third party, transferring policy benefits to an unrelated person, showing unusual interest in early termination or borrowing while ignoring performance, refusing identifying information, or borrowing the maximum soon after purchase. A red flag is a reason to follow the insurer’s review process, not proof that the customer laundered money.

Context changes the meaning of a transaction. A customer may surrender a policy because of a job loss, illness, family change, or misunderstanding of an illustration. A third party might pay premiums for a legitimate family or business reason. An unusually large premium can come from a lawful inheritance or asset sale. The agent should record what the customer says and collect documents required by the carrier; the agent should not accuse the customer or decide guilt from one fact.

Patterns are often more important than a single transaction. A customer who buys a cash-value policy with a large premium, promptly borrows against it, assigns it to an unrelated person, and requests surrender or refund to another account may raise more questions than any one event viewed alone. The agent should report observations promptly through the insurer’s designated channel and answer compliance follow-up truthfully.

A practical response when something feels unusual

1. Pause before promising that a payment method or transaction is acceptable. Check the carrier’s current AML instructions for the product.
2. Ask neutral, permitted questions needed to complete the application or understand the funding source. Do not conduct an improvised interrogation.
3. Record the customer’s explanation accurately and preserve source documents the carrier requests.
4. Escalate the facts through the insurer’s compliance or AML reporting channel. Share only with people authorized to receive the information.
5. Continue ordinary customer service only as the insurer instructs. Compliance may request more information, pause a transaction, or decline it.
6. Do not tell the customer that a SAR was or may be filed, and do not hint that a report exists.
7. Keep the matter confidential and follow retention and document-security rules.

SARs: the insurer decides and secrecy matters

Under 31 CFR §1025.320, an insurance company must report certain suspicious transactions involving or aggregating at least $5,000 when the regulatory knowledge or suspicion standard is met. The rule covers transactions conducted or attempted by, at, or through the insurance company and includes specific categories such as funds suspected to involve illegal activity, transactions designed to evade BSA requirements, or transactions with no apparent lawful purpose. The company evaluates the facts and makes the filing decision.

A SAR is not an accusation or finding of guilt. It is a confidential report of suspicious activity to FinCEN. The SAR and information that would reveal its existence generally may not be disclosed to the customer or other unauthorized people. Agents should not tell a client “we filed a SAR,” “compliance is reporting you,” or “we cannot proceed because of the SAR.” If asked about a transaction restriction, follow the company’s approved explanation without revealing protected reporting.

The insurer’s obligation to report does not usually mean the agent files a separate insurance SAR as an agent. The agent provides relevant information to the company and follows instructions. Certain agents may have independent obligations in another regulated capacity, such as as a broker-dealer. If the insurer’s counsel or compliance team asks the agent to preserve records or respond to regulators, use the prescribed process and do not disclose SAR details outside authorized channels.

Premium payments, cash, and records

A premium paid by cash or an unusual instrument is a fact to assess under the carrier’s rules, but not automatically illegal. Insurer procedures may restrict accepted payment methods or set limits. Do not split payments to evade a company control, accept money from an unidentified person without required documentation, or return funds to a different party or account without authorization. The premium payer, policy owner, insured, and beneficiary can be different people, but the carrier needs to understand the arrangement.

Keep application records, premium receipts, identity information, disclosures, and communications in approved systems. Do not keep extra copies of sensitive financial documents on a personal device. If the customer changes the payer or asks to redirect a refund, document the request and obtain carrier approval. AML review and customer privacy coexist: collect what the insurer requires, limit access, and protect information.

Cash transaction reporting under other federal rules is distinct from a SAR. FinCEN guidance discusses Form 8300 for certain cash received in a trade or business and separate suspicious-activity reports. Agents should not calculate or file a form based on memory; route a potentially reportable payment to insurer compliance, which determines the company’s legal obligations and required filings.

Worked examples

Example 1: early surrender with a third-party refund

A customer purchases a cash-value policy with a large single premium, asks how soon it can be surrendered, and requests that the refund go to an unrelated account. Those facts match several FinCEN red-flag examples. The agent should not accuse the customer or promise a refund. The agent records the request, follows the carrier’s third-party payment controls, and escalates the facts to compliance.

Example 2: term application with a cash premium

A customer wants term life coverage and offers cash. Term life generally is not a covered product under the insurance-company AML product rule, but the insurer may have payment controls and other legal obligations. The agent uses the carrier’s payment procedure instead of saying that all AML rules are irrelevant or that the customer is suspicious solely because cash was offered.

Example 3: unusual product that has a reasonable explanation

A customer buys a permanent policy and soon requests a loan to cover a medical bill. The timing could attract review, but the reason may be legitimate. The agent documents the explanation and sends it through the insurer’s process. Compliance—not the agent—decides whether the transaction warrants a SAR.

Common exam traps

• Saying agents must independently maintain a separate AML program under the insurance-company rule. The insurer owns the program but integrates and monitors agents.
• Applying the covered-product rule to all life insurance. Ordinary term and group life are generally excluded from the defined covered products.
• Calling every cash-value policy covered without checking whether it is group or has investment/cash-value features.
• Treating a red flag as proof of money laundering.
• Telling the customer that a SAR was filed or will be filed.
• Assuming the agent files the insurer’s SAR. The insurer determines and makes the filing under this rule.
• Ignoring suspicious activity because a product is legally issued or the customer is licensed.
• Returning premiums to a different party without approval and verification.
• Confusing a SAR with a Currency Transaction Report or Form 8300.
• Assuming all AML duties disappear when an agent also has duties under another license or law.

What to remember

FinCEN’s insurance AML program is centered on the insurer and products with cash-value or investment features. The insurer must bring its agents into the program and monitor compliance. The agent recognizes red flags, follows carrier controls, preserves accurate information, and escalates concerns without accusing the customer. SARs remain confidential; never disclose or hint at their existence.